You are here

pharmaceutical

UAE’s Mubadala acquires full ownership of UCB Pharma’s China business with CBC Group

UAE’s Mubadala acquires full ownership of UCB Pharma’s China business with CBC Group

  • Value of transaction is expected to close in fourth quarter of 2024
  • Deal includes UCB’s neurology and allergy portfolios
By MIGUEL HADCHITY  ·

Opinion

Faisal J. Abbas
Saudi reforms: the show must go on
Author
Mohamed Chebaro
Imbalances, instability threaten EU’s future
Author
Daoud Kuttab
Settler monster is stealing Jerusalem’s authentic tale
Author
Dr. Dania Koleilat Khatib
Jordan, Egypt at forefront of resistance to Israel’s annexation plans
Author
Dr. Azeem Ibrahim
What the Arakan Army’s rise means for the Rohingya
Author
More in Opinion

Latest updates

Saudi’s Hail region welcomes over 1.1m tourists in H1
Saudi’s Hail region welcomes over 1.1m tourists in H1
Spike Lee to preside over Red Sea International Film Festival jury
Spike Lee to preside over Red Sea International Film Festival jury
Saudi entertainment sector to create 450,000 jobs by 2030: Investment ministry
Saudi entertainment sector to create 450,000 jobs by 2030: Investment ministry
US envoy to meet Israel’s Netanyahu on Thursday: spokesman
US envoy to meet Israel’s Netanyahu on Thursday: spokesman
Dozens feared dead in Gaza after Israeli strikes
Dozens feared dead in Gaza after Israeli strikes

Recommended

Middle-East
How Israel’s UNRWA ban will impact Palestinians in Gaza and the West Bank
How Israel’s UNRWA ban will impact Palestinians in Gaza and the West Bank
Middle-East
First responders in the line of fire as Israel and Hezbollah battle it out in Lebanon
First responders in the line of fire as Israel and Hezbollah battle it out in Lebanon
Business & Economy
Annual Dubai forum dedicated to futurism explores ways to ‘empower generations’
Annual Dubai forum dedicated to futurism explores ways to ‘empower generations’

Search form

Print Edition
Read pdf version Subscribe now
© 2024 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.